Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Hart

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|July 20, 2007
Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumorF J P Hoebers, D Pluim, A A M Hart, et al.
The American Journal of Surgical Pathology|August 19, 2008
Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotypeAmy Heerema-McKenney, Liliane C D Wijnaendts, Joseph F Pulliam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?Tom W Geurts, Petra M Nederlof, Michiel W M van den Brekel, et al.
Breast Cancer Research : BCR|October 31, 2006
Predicting a local recurrence after breast-conserving therapy by gene expression profilingDimitry S A Nuyten, Bas Kreike, Augustinus A M Hart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomasR L M Haas, Ph Poortmans, D de Jong, et al.
Cancer|March 11, 2003
Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group databaseVincent L M Vander Poorten, Augustinus A M Hart, Bernardus F A M van der Laan, et al.
Blood|November 23, 2006
Late cardiotoxicity after treatment for Hodgkin lymphomaBerthe M P Aleman, Alexandra W van den Belt-Dusebout, Marie L De Bruin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trialHeather A Jones, Ninja Antonini, Augustinus A M Hart, et al.
Nature|February 2, 2002
Gene expression profiling predicts clinical outcome of breast cancerLaura J van 't Veer, Hongyue Dai, Marc J van de Vijver, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 2005
Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluationRoel J H M Steenbakkers, Joop C Duppen, Isabelle Fitton, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|July 20, 2007
Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumorF J P Hoebers, D Pluim, A A M Hart, et al.
The American Journal of Surgical Pathology|August 19, 2008
Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotypeAmy Heerema-McKenney, Liliane C D Wijnaendts, Joseph F Pulliam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?Tom W Geurts, Petra M Nederlof, Michiel W M van den Brekel, et al.
Breast Cancer Research : BCR|October 31, 2006
Predicting a local recurrence after breast-conserving therapy by gene expression profilingDimitry S A Nuyten, Bas Kreike, Augustinus A M Hart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomasR L M Haas, Ph Poortmans, D de Jong, et al.
Cancer|March 11, 2003
Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch Head and Neck Oncology Cooperative Group databaseVincent L M Vander Poorten, Augustinus A M Hart, Bernardus F A M van der Laan, et al.
Blood|November 23, 2006
Late cardiotoxicity after treatment for Hodgkin lymphomaBerthe M P Aleman, Alexandra W van den Belt-Dusebout, Marie L De Bruin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trialHeather A Jones, Ninja Antonini, Augustinus A M Hart, et al.
Nature|February 2, 2002
Gene expression profiling predicts clinical outcome of breast cancerLaura J van 't Veer, Hongyue Dai, Marc J van de Vijver, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 2005
Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluationRoel J H M Steenbakkers, Joop C Duppen, Isabelle Fitton, et al.
Pageof 10